GSK Antibiotic Retapamulin Has September User Fee Date
This article was originally published in The Pink Sheet Daily
GlaxoSmithKline's topical antibacterial retapamulin has a September user fee date
You may also be interested in...
$50 mil. acquisition of the Croatian lab that gave Pfizer Zithromax could provide GSK with a successor to Augmentin.
Roche will consider requesting a re-examination of the negative decision by the Committee for Medicinal Products for Human Use.